Citigroup
LYEL icon

Citigroup’s Lyell Immunopharma LYEL Stock Holding History

Citigroup’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.6K Sell
5,025
-887
-15% -$16.1K ﹤0.01% 4857
2026
Q1 		$119K Buy
5,912
+1,679
+40% +$39.2K ﹤0.01% 4218
2025
Q4 		$130K Buy
4,233
+3,203
+311% +$71.7K ﹤0.01% 4197
2025
Q3 		$16.7K Sell
1,030
-1,025
-50% -$11.7K ﹤0.01% 4876
2025
Q2 		$18.2K Sell
2,055
-3,840
-65% -$35K ﹤0.01% 5100
2025
Q1 		$63.4K Sell
5,895
-699
-11% -$8.56K ﹤0.01% 4811
2024
Q4 		$84.4K Buy
6,594
+129
+2% +$2.56K ﹤0.01% 4921
2024
Q3 		$178K Buy
6,465
+3,998
+162% +$117K ﹤0.01% 4418
2024
Q2 		$71.6K Buy
2,467
+83
+3% +$3.95K ﹤0.01% 4385
2024
Q1 		$106K Sell
2,384
-1,403
-37% -$60.1K ﹤0.01% 4265
2023
Q4 		$147K Sell
3,787
-5,900
-61% -$212K ﹤0.01% 4059
2023
Q3 		$285K Buy
9,687
+1,611
+20% +$76.5K ﹤0.01% 3443
2023
Q2 		$514K Sell
8,076
-12,760
-61% -$706K ﹤0.01% 3348
2023
Q1 		$983K Buy
20,836
+7,303
+54% +$391K ﹤0.01% 2571
2022
Q4 		$939K Buy
13,533
+3,200
+31% +$318K ﹤0.01% 2655
2022
Q3 		$1.51M Buy
10,333
+8,733
+546% +$1.18M ﹤0.01% 2371
2022
Q2 		$208K Sell
1,600
-482
-23% -$49.2K ﹤0.01% 3830
2022
Q1 		$210K Sell
2,082
-292
-12% -$35.4K ﹤0.01% 4053
2021
Q4 		$368K Buy
2,374
+2,239
+1,659% +$499K ﹤0.01% 3996
2021
Q3 		$40K Buy
+135
New +$40.4K ﹤0.01% 4867

Other funds holding LYEL

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Citigroup's LYEL Position: Q2 2026 in Review

Citigroup reduced its Lyell Immunopharma (LYEL) stake by 15% in Q2 2026, selling an estimated $16.1K and leaving 5,025 shares worth $70.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4857.

Citigroup first reported a position in LYEL in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.51M in Q3 2022. 8 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Citigroup held 5,025 shares of Lyell Immunopharma worth $70.6K as of Q2 2026.
  • Citigroup sold 887 Lyell Immunopharma shares in Q2 2026, an estimated $16.1K.
  • Lyell Immunopharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4857 holding.
  • Citigroup first reported a position in Lyell Immunopharma in Q3 2021 and has held it in 20 quarters since.
  • Citigroup's Lyell Immunopharma position peaked at $1.51M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.